The CRISPR-Cas12a Platform for Accurate Genome Editing, Gene Disruption, and Efficient Transgene Integration in Human Immune Cells

Marina Mohr,Nkerorema Damas,Johanne Gudmand-Høyer,Katrine Zeeberg,Dominika Jedrzejczyk,Arsenios Vlassis,Sara Pereira-Schoning,Anna Oliver-Almirall,Tanja Lyholm Jensen,Roland Baumgartner,Brian Tate Weinert,Ryan T. Gill,Tanya Warnecke,Martí Morera-Gómez,Urška Puš
DOI: https://doi.org/10.1021/acssynbio.2c00179
IF: 5.249
2023-02-09
ACS Synthetic Biology
Abstract:CRISPR-Cas12a nucleases have expanded the toolbox for targeted genome engineering in a broad range of organisms. Here, using a high-throughput engineering approach, we explored the potential of a novel CRISPR-MAD7 system for genome editing in human cells. We evaluated several thousand optimization conditions and demonstrated accurate genome reprogramming with modified MAD7. We identified crRNAs that allow for ≤95% non-homologous end joining (NHEJ) and 66% frameshift mutations in various genes...
biochemical research methods
What problem does this paper attempt to address?